Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 2015

View Archived Issues

Preclinical results presented for a BAX activator molecule

Sunitinib shows antitumor activity in thyroid cancer patients

Prozymex reports development of DPP-I inhibitors

University of Texas System patent describes new engineered primate L-methioninase

Peloton Therapeutics presents HIF-2alpha inhibitors

Dako and Amgen expand companion diagnostics collaboration

Scientists design novel PHEO mouse model

Imaging agent 64Cu-DOTA-AE-105 tested in prostate cancer patients

Further clinical data reported for preregistered hypercholesterolemia treatment evolocumab

La Jolla initiates phase III trial of LJPC-501 for catecholamine-resistant hypotension

ThromboGenics reports topline data on Jetrea in symptomatic vitreomacular adhesion

Nippon Shinyaku to continue clinical development of NS-065 for DMD

GenVec and TheraBiologics to develop cancer therapies based on neural stem cell technology

New S1P1 antagonist presented for the treatment of autoimmune disease

Gilead's sofosbuvir approved in Japan for genotype 2 HCV infection

Regulus receives European orphan medicinal product designation for RG-012

FDA approves Regeneron's aflibercept for diabetic retinopathy in diabetic macular edema

Quadracel approved in U.S. for vaccination of children aged 4-6 years

EUSA Pharma regains independence from Jazz Pharmaceuticals

Università degli Studi di Padova describes use of SERPINB3 for SLE

Therapure Innovations receives FDA approval to conduct phase I trial of TBI-302

Calitor Sciences discloses ALK and/or HGFR inhibitors

Sun Pharmaceutical completes acquisition of Ranbaxy from Daiichi Sankyo

FDA approves Emergent BioSolutions' Anthrasil for treatment of inhalational anthrax

MBX-8025 gains U.S. orphan drug status for homozygous familial hypercholesterolemia

Lilly's Cyramza obtains approval for gastric cancer in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...